Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT02187757
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT02187757
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT02187757. Randomized; quadruple masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels
- Acronym
- Prelip
- Condition
- Hyperlipidemia
- Intervention (Dietary supplement)
- Study Dietary Supplement (Prelipid 500 mg capsules)
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- PreEmptive Meds, Pvt. Ltd
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct02187757- Content hash
46bc8f012c2db7179ad1ce8c614697cfe83f2d49477c9a487ac992a006dfee54